CAS 155820-63-6

benzyl 2-bromo-2,2-difluoroacetate

Description:

Benzyl 2-bromo-2,2-difluoroacetate is an organic compound characterized by its unique structure, which includes a benzyl group and a difluoroacetate moiety. This compound features a bromine atom and two fluorine atoms attached to the carbon adjacent to the ester functional group, contributing to its reactivity and potential applications in synthetic chemistry. It is typically a colorless to pale yellow liquid with a distinctive odor. The presence of the bromine and fluorine atoms enhances its electrophilic character, making it useful in various chemical reactions, including nucleophilic substitutions. The compound is soluble in organic solvents, which facilitates its use in laboratory settings. Due to the presence of halogens, it may exhibit specific biological activities, although detailed toxicity and safety data should be consulted for handling. Overall, benzyl 2-bromo-2,2-difluoroacetate serves as an important intermediate in the synthesis of pharmaceuticals and agrochemicals, showcasing the significance of halogenated compounds in organic synthesis.

Formula: C₉H₇BrF₂O₂

Synonyms:

• benzyl 2-bromo-2,2-difluoroacetate

Benzyl 2-Bromo-2,2-Difluoroacetate

CAS: 155820-63-6

Formula: C₉H₇BrF₂O₂

Purity: 95%

Molecular weight: 265.0515

Ref: IN-DA01B57P

Benzyl 2-bromo-2,2-difluoroacetate

CAS: 155820-63-6

Benzyl 2-bromo-2,2-difluoroacetate

Purity: 95%

Molecular weight: 265.05g/mol

Ref: 54-PC1007520

Benzyl 2-bromo-2,2-difluoroacetate

CAS: 155820-63-6

Benzyl 2-bromo-2,2-difluoroacetate (BBDFA) is a synthetic drug that is used as an inhibitor of human leukocyte elastase. It is used in diagnostic and industrial process to inhibit the proteolytic activity of leukocyte elastase. This compound has been shown to be effective in the treatment of degenerative diseases such as Alzheimer's disease and Parkinson's disease. The inhibition of leukocyte elastase by BBDFA may provide a therapeutic benefit by reducing the levels of extracellular matrix degradation products from tissue or organs. Benzyl 2-bromo-2,2-difluoroacetate is synthesized by reacting cyclic acetal with bromine followed by reaction with difluoroacetic acid. The compound inhibits the enzyme proteolytic through binding to its active site, which blocks access to substrate peptides.

Formula: C₉H₇BrF₂O₂

Purity: Min. 95%

Molecular weight: 265.05 g/mol

Ref: 3D-FGA82063